Morpholino

MO1-adora2ab

ID

ZDB-MRPHLNO-181019-3

Name

MO1-adora2ab

Previous Names

None

Target

adora2ab (1)

Sequence

5' - GAACAATGTAGACGAGAGAAGACAT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Translation-blocking MO, targets the 5'UTR.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-adora2ab

No data available

Phenotype

Phenotype resulting from MO1-adora2ab

Phenotype	Fish	Figures
caudal fin deformed, abnormal	WT + MO1-adora2ab	Fig. 5 from Menezes et al., 2018
eye decreased size, abnormal	WT + MO1-adora2ab	Fig. 1, Fig. 5 from Menezes et al., 2018
pericardium edematous, abnormal	WT + MO1-adora2ab	Fig. 1, Fig. 5 from Menezes et al., 2018
swim bladder absent, abnormal	WT + MO1-adora2ab	Fig. 5 from Menezes et al., 2018
whole organism Ab1-adora2a labeling decreased amount, abnormal	WT + MO1-adora2ab	Fig. 2 from Menezes et al., 2018
whole organism decreased life span, abnormal	WT + MO1-adora2ab	Fig. 3 from Menezes et al., 2018
whole organism morphology, abnormal	WT + MO1-adora2ab	Fig. 4 from Menezes et al., 2018

Phenotype of all Fish created by or utilizing MO1-adora2ab

Phenotype	Fish	Conditions	Figures
eye decreased size, abnormal	WT + MO1-adora2ab	standard conditions	Fig. 1, Fig. 5 from Menezes et al., 2018
whole organism Ab1-adora2a labeling decreased amount, abnormal	WT + MO1-adora2ab	standard conditions	Fig. 2 from Menezes et al., 2018
caudal fin deformed, abnormal	WT + MO1-adora2ab	standard conditions	Fig. 5 from Menezes et al., 2018
pericardium edematous, abnormal	WT + MO1-adora2ab	standard conditions	Fig. 1, Fig. 5 from Menezes et al., 2018
whole organism morphology, abnormal	WT + MO1-adora2ab	standard conditions	Fig. 4 from Menezes et al., 2018
behavior process quality, exacerbated	WT + MO1-adora2ab	chemical treatment by environment: pentetrazol	Fig. 9 from Menezes et al., 2018
swim bladder absent, abnormal	WT + MO1-adora2ab	standard conditions	Fig. 5 from Menezes et al., 2018
behavior process quality, abnormal	WT + MO1-adora2ab	chemical treatment by environment: pentetrazol	Fig. 8 from Menezes et al., 2018
whole organism decreased life span, abnormal	WT + MO1-adora2ab	standard conditions	Fig. 3 from Menezes et al., 2018
eye decreased size, abnormal	WT + MO1-adora2ab + MO3-adora2aa	standard conditions	Fig. 1, Fig. 5 from Menezes et al., 2018
whole organism Ab1-adora2a labeling decreased amount, abnormal	WT + MO1-adora2ab + MO3-adora2aa	standard conditions	Fig. 2 from Menezes et al., 2018
locomotion involved in locomotory behavior process quality, abnormal	WT + MO1-adora2ab + MO3-adora2aa	standard conditions	Fig. 6 from Menezes et al., 2018
pericardium edematous, abnormal	WT + MO1-adora2ab + MO3-adora2aa	standard conditions	Fig. 5 from Menezes et al., 2018
behavior process quality, exacerbated	WT + MO1-adora2ab + MO3-adora2aa	chemical treatment by environment: pentetrazol	Fig. 9 from Menezes et al., 2018
swim bladder absent, abnormal	WT + MO1-adora2ab + MO3-adora2aa	standard conditions	Fig. 5 from Menezes et al., 2018
whole organism morphology, abnormal	WT + MO1-adora2ab + MO3-adora2aa	standard conditions	Fig. 4 from Menezes et al., 2018
caudal fin deformed, abnormal	WT + MO1-adora2ab + MO3-adora2aa	standard conditions	Fig. 1, Fig. 5 from Menezes et al., 2018
whole organism decreased life span, abnormal	WT + MO1-adora2ab + MO3-adora2aa	standard conditions	Fig. 3 from Menezes et al., 2018
behavior process quality, abnormal	WT + MO1-adora2ab + MO3-adora2aa	chemical treatment by environment: pentetrazol	Fig. 8 from Menezes et al., 2018

Citations